pone.0241454.s002.tiff (943.44 kB)
Analysis for overall survival (OS) and disease-specific survival (DSS) related to each gene mutation.
figure
posted on 2021-05-20, 17:49 authored by Akiyoshi Tsuboi, Yuji Urabe, Shiro Oka, Akihiko Sumioka, Sumio Iio, Ryo Yuge, Ryohei Hayashi, Toshio Kuwai, Yasuhiko Kitadai, Kazuya Kuraoka, Koji Arihiro, Shinji Tanaka, Kazuaki Chayama(a) OS of patients with small-bowel cancer and mutations in TP53 (A), KRAS (B), PIK3CA (C), and SMAD4 (D). (b) DSS of patients with small-bowel cancer and mutations in TP53 (A), KRAS (B), PIK3CA (C), and SMAD4 (D). There were no significant differences in survival associated with any gene mutation.
(TIFF)
